Researcher
Natacha Herssens
Affiliations
- Clinical Trials Unit (Research unit)
Member
From15 Apr 2013 → Today
Projects
1 - 1 of 1 results
Publications
1 - 6 of 6 results
- Finding the right balance between efficacy and tolerability for TB treatment: the search continues(2021)
Authors: A.K.J. Maug, M A Hossain, G Mourad, Tom Decroo, Wim Mulders, Sofie Braet, Jozefien Buyze, D A Jiménez, Céline Schurmans, Natacha Herssens, et al.
Pages: 84-86Number of pages: 3 - First-line tuberculosis treatment with double-dose rifampicin is well tolerated(2020)
Authors: A.K.J. Maug, M A Hossain, Mourad Gumusboga, Tom Decroo, Wim Mulders, Sofie Braet, Jozefien Buyze, Diana Arango, Céline Schurmans, Natacha Herssens, et al.
Pages: 499-505Number of pages: 7 - Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on-going viral transcription(2020)
Authors: Pieter Pannus, Sofie Rutsaert, Stéphane De Wit, Sabine D. Allard, G Vanham, Basiel Cole, Coca Nescoi, Joeri Aerts, Ward De Spiegelaere, Achilleas Tsoumanis, et al.
Pages: e25453 - The XN-30 hematology analyzer for rapid sensitive detection of malaria: a diagnostic accuracy study(2019)
Authors: Annelies Post, Berenger Kaboré, Isaie J Reuling, Joel Bognini, Wouter van der Heijden, Salou Diallo, Palpouguini Lompo, Basile Kam, Natacha Herssens, Kjerstin Lanke, et al.
Pages: 103 - Comparative immunogenicity and safety trial of 2 different schedules of single-visit intradermal rabies postexposure vaccination(2019)
Authors: Patrick Soentjens, Katrien De Koninck, Achilleas Tsoumanis, Natacha Herssens, Dorien Van Den Bossche, Sanne Terryn, Steven Van Gucht, Pierre Van Damme, Yven Van Herrewege, Emmanuel Bottieau
Pages: 797-804Number of pages: 8 - Discriminatory capacity between HIV-1 and HIV-2 of the new rapid confirmation assay Geenius(2014)
Authors: Natacha Herssens, G. Beelaert, K. Fransen
Pages: 11-15Number of pages: 5